Palatin Technologies (PTN) Non Operating Investment Income (2010 - 2016)
Palatin Technologies' (PTN) quarterly Non Operating Investment Income came in at $6819.0 in Q1 2016, down 27.37% on a QoQ basis from $9389.0 in Q4 2015.
Palatin Technologies (PTN) Non Operating Investment Income (2010 - 2016) Analysis & Trends
Palatin Technologies (PTN) has 4 years of Non Operating Investment Income data on file, last reported at $6819.0 in Q1 2016.
- Quarterly Non Operating Investment Income changed N/A year-over-year to $6819.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $16208.0 (down 72.51% YoY) and the FY2011 annual result came in at $119346.0, changed N/A from the prior year.
- Non Operating Investment Income declined to $6819.0 in Q1 2016, from $9389.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $9389.0 in Q4 2015 to a low of $6819.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 6,819.00 |
| Mar 31, 2016 | 6,819.00 |
| Dec 31, 2015 | 9,389.00 |
| Dec 31, 2015 | 9,389.00 |
| Mar 31, 2011 | 58,956.00 |
| Mar 31, 2011 | 58,956.00 |
| Dec 31, 2010 | 60,390.00 |
| Dec 31, 2010 | 60,390.00 |